Merck & Co said on Friday it will pay $100 million to resolve all U.S. product liability lawsuits alleging it downplayed serious health risks involving its NuvaRing intrauterine contraceptive device. The product, which contains the hormones estrogen and progestin commonly found in birth control bills, is associated with an increased risk of developing blood clots that can cause heart attacks, strokes or sudden deaths. Available to women in the United States since 2001, NuvaRing is one of several contraceptive products linked to this higher risk. Merck, the second-biggest U.S. drugmaker, denied any fault under the agreement, which must be accepted by 95 percent of about 3,800 eligible patients involved in lawsuits pending in federal and state courts. A lawyer for the plaintiffs, Roger Denton of Schlichter, Bogard and Denton, said the settlement, reached after nearly a year of negotiations, is "an outstanding result and in the best interests of all the women who have suffered an injury associated with the use of Nuvaring." Under the settlement, Merck would pay a fraction of what at least one company has paid in a similar settlement. German drugmaker Bayer AG said last year it had paid nearly $1.6 billion to settle thousands of lawsuits involving accusations that its Yaz and Yazmin birth control pills caused blood clots that led to strokes and heart attacks. Merck shares were up 1 percent at $54.32 on the New York Stock Exchange, in line with a 1.2-percent... |
The companies that make helmets and mouth guards often claim that their own products can reduce players’ risk of a sports-related concussion or lessen the impact of a concussion that does occur. These manufacturers cite “laboratory research” that purports to show one brand is safer than others, and a group of researchers wanted to see if they could verify such claims, according to a summary of a presentation they made Monday at a national meeting of the American Academy of Pediatrics.
The research team, from the University of Wisconsin-Madison and the Medical College of Wisconsin, tracked 1,332 high school football players from 36 schools during the 2012 season. Participating players completed a preseason questionnaire about their injury history and demographic information. Then, as the season progressed, athletic trainers from the schools kept tabs on the incidence and severity of any concussions that occurred.
At the start of the study, 171 of the players — or 13% — told the researchers that they had experienced a sports-related concussion in the previous 12 months. During the 2012 football season, an additional 116 concussions were sustained by 115 players — 8.6% of the student athletes in the study.
When the researchers compared...
The research team, from the University of Wisconsin-Madison and the Medical College of Wisconsin, tracked 1,332 high school football players from 36 schools during the 2012 season. Participating players completed a preseason questionnaire about their injury history and demographic information. Then, as the season progressed, athletic trainers from the schools kept tabs on the incidence and severity of any concussions that occurred.
At the start of the study, 171 of the players — or 13% — told the researchers that they had experienced a sports-related concussion in the previous 12 months. During the 2012 football season, an additional 116 concussions were sustained by 115 players — 8.6% of the student athletes in the study.
When the researchers compared...